Schedule 13G ownership disclosure

Protagonist Therapeutics Inc

Common Stock, $0.00001 par value · CUSIP: 74366E102

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RTW Investments, LP

    Shares: 5,059,053.00 · Class: 8.1%

  • Roderick Wong

    Shares: 5,059,053.00 · Class: 8.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493215-26-000042
Form type
SCHEDULE 13G/A
Filer
Protagonist Therapeutics, Inc
CIK
CIK 1377121
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub